| S8281 |
CCF642
|
CCF642 (AC1LYELL) is a novel PDI-inhibiting compound with antimyeloma activity.
|
-
Cell Mol Gastroenterol Hepatol, 2023, S2352-345X(23)00025-5
-
Int J Mol Sci, 2022, 23(24)15834
|
|
| S0321 |
LOC14
|
LOC14 is a potent inhibitor of protein disulfide isomerase (PDI) with EC50 of 500 nM and Kd of 62 nM, respectively.
|
|
|
| S2846 |
ML359
|
ML359 is a small molecule inhibitor of protein disulfide isomerase (PDI).
|
|
|
| E6697New |
PACMA 31
|
PACMA 31 is an irreversible, orally active inhibitor of protein disulfide isomerase (PDI) with an IC50 of 10 μM. It covalently binds PDI's active-site cysteines, inhibiting reductase/isomerase activity in a dose- and time-dependent manner per insulin aggregation assays.
|
|
|